Characterization of Vasorelaxant Principles from the Needles of Pinus morrisonicola Hayata.

about

Characterization of Vasorelaxant Principles from the Needles of Pinus morrisonicola Hayata.

Item

http://www.wikidata.org/entity/Q47209338

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Characterization of Vasorelaxa ...... of Pinus morrisonicola Hayata.

@en

Characterization of Vasorelaxa ...... of Pinus morrisonicola Hayata.

@nl

type

Item

label

Characterization of Vasorelaxa ...... of Pinus morrisonicola Hayata.

@en

Characterization of Vasorelaxa ...... of Pinus morrisonicola Hayata.

@nl

prefLabel

Characterization of Vasorelaxa ...... of Pinus morrisonicola Hayata.

@en

Characterization of Vasorelaxa ...... of Pinus morrisonicola Hayata.

@nl

P1476

Characterization of Vasorelaxa ...... of Pinus morrisonicola Hayata

@en

P2093

Guan-Heng Chen

http://www.w3.org/2001/XMLSchema#string

Jason T C Tzen

http://www.w3.org/2001/XMLSchema#string

Nan-Hei Lin

http://www.w3.org/2001/XMLSchema#string

Yue-Chiun Li

http://www.w3.org/2001/XMLSchema#string

P2860

The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

Structural Basis for Pharmacology of Voltage-Gated Sodium and Calcium Channels

A review of the French maritime pine bark extract (Pycnogenol), a herbal medication with a diverse clinical pharmacology

Pycnogenol, French maritime pine bark extract, augments endothelium-dependent vasodilation in humans

Characterization of flavonoid glycosides from fenugreek (Trigonella foenum-graecum) crude seeds by HPLC-DAD-ESI/MS analysis

Calcium channel blockers and cancer: a risk analysis using the UK Clinical Practice Research Datalink (CPRD).

Calcium channel antagonists: clinical uses--past, present and future.

Resistant hypertension: an overview of evaluation and treatment.

Enhancing the potency of lithospermate B for inhibiting Na+/K+-ATPase activity by forming transition metal ion complexes.

P31

scholarly article

P356

10.3390/MOLECULES23010086

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ping-Chung Kuo

P577

2017-12-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29301239

http://www.w3.org/2001/XMLSchema#string

P932

6017640

http://www.w3.org/2001/XMLSchema#string